Kuvatris Therapeutics, Inc.
Pharmaceutical company · Tarrytown, New York, United States
Kuvatris Therapeutics, Inc. is a pharmaceutical company headquartered in Tarrytown, New York, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $1.1 million sold in a notice filed in 2022.
Kuvatris Therapeutics at a glance
What does Kuvatris Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.1 million sold (2022).
Frequently asked questions about Kuvatris Therapeutics
Where is Kuvatris Therapeutics headquartered?
Kuvatris Therapeutics, Inc. is headquartered in Tarrytown, New York, United States.
What does Kuvatris Therapeutics do?
Kuvatris Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Kuvatris Therapeutics founded?
The earliest incorporation on record for Kuvatris Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Regeneron Pharmaceuticals, Inc.Tarrytown, New York, United States
- Prestige Consumer Healthcare Inc.Tarrytown, New York, United States
- Araim Pharmaceuticals, Inc.Tarrytown, New York, United States
- Visiox Pharma, LLCTarrytown, New York, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences